Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutation
Gerhard Hamilton, Sandra Stickler, Mikhail Ermakov, Marie-Therese Eggerstorfer, Francesca Paola Nocera, Martin Hohenegger, Lukas Weigl, Maximilian Johannes Hochmair, Karl Kashofer · 2024
Read Characterization of the BH1406 non-small cell lung cancer (NSCLC) cell line carrying an activating SOS1 mutation by Gerhard Hamilton, Sandra Stickler, Mikhail Ermakov, Marie-Therese Eggerstorfer, Francesca Paola Nocera, Martin Hohenegger, Lukas Weigl, Maximilian Johannes Hochmair, Karl Kashofer (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11632420.txt.
Description
Gerhard Hamilton and eight co-authors profile a lung cancer cell line that carries a rare switch-on fault in the SOS1 gene. Their 2024 study starts from a puzzle: about thirty percent of lung cancer patients have no known driver fault, so they miss targeted drugs. The cell line, grown from fluid around a patient's lung, reacted to an SOS1 blocker in early screens.
Deep gene scans found the fault, a small rewrite near a known hot spot. The cells proved sensitive to three SOS1 blockers, more so in three-dimensional growth than flat. The blockers also quieted key growth signals inside the cells. Partner drugs from three other classes boosted the effect. The authors offer the line as a test bed for SOS1 drug research.
Catalog record
| CREATOR | Gerhard Hamilton, Sandra Stickler, Mikhail Ermakov, Marie-Therese Eggerstorfer, Francesca Paola Nocera, Martin Hohenegger, Lukas Weigl, Maximilian Johannes Hochmair, Karl Kashofer |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |